OTCMKTS:PURE PURE Bioscience (PURE) Stock Forecast, Price & News $0.11 +0.00 (+3.77%) (As of 09/22/2023 08:53 PM ET) Add Compare Share Share Today's Range$0.10▼$0.1150-Day Range$0.08▼$0.1352-Week Range$0.07▼$0.22Volume44,100 shsAverage Volume37,580 shsMarket Capitalization$12.30 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort Interest About PURE Bioscience (OTCMKTS:PURE) StockPURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.Read More PURE Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PURE Stock News HeadlinesSeptember 20, 2023 | bizjournals.comLayoffs hit Morrisville firm as it scales back operationsSeptember 2, 2023 | msn.comCoffee, dolphins & other favorite things that might not exist in 30 yearsSeptember 25, 2023 | Edge On The Street (Ad)An Unusual Way to Invest in GoldMost financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines. September 2, 2023 | msn.comSaavy Naturals: What Happened To The Brand After Shark Tank?August 30, 2023 | finance.yahoo.comWILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTAugust 19, 2023 | msn.comThe Common Food Processing Step That's Detrimental To Our HealthAugust 8, 2023 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSAugust 3, 2023 | bizjournals.comMost Influential Business Women 2023: Gabriela Ramirez-Arellano helps entrepreneurs achieve their dreamsSeptember 25, 2023 | Edge On The Street (Ad)An Unusual Way to Invest in GoldMost financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines. August 2, 2023 | finance.yahoo.comWILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9July 29, 2023 | finance.yahoo.comPURE - PURE Bioscience, Inc.June 16, 2023 | finance.yahoo.comVinamilk forms strategic partnerships with top global companies and receives Purity Award for children's milk powderJune 16, 2023 | benzinga.comPURE Bioscience Stock (OTC:PURE), DividendsJune 14, 2023 | msn.comPURE Bioscience GAAP EPS of -$0.01, revenue of $0.41MJune 14, 2023 | finance.yahoo.comPURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial ResultsJune 14, 2023 | markets.businessinsider.comWhy Is NightHawk Biosciences (NHWK) Stock Up 26% Today?June 13, 2023 | yahoo.comWorld's most painful ant sting targets nerves in the same way scorpion venom doesJune 7, 2023 | finance.yahoo.comWILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14June 2, 2023 | msn.comTerran Biosciences Seals Deal With France's Pierre Fabre PharmaceuticalJune 2, 2023 | markets.businessinsider.comTerran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan; Terran completes key development milestonesMay 16, 2023 | marketwatch.comRosiglitazone Maleate Market | Worldwide Industry Trends 2023-2030May 12, 2023 | marketwatch.comSilver-based Antimicrobial Agent Market Size and Research Overview 2023-2030May 12, 2023 | benzinga.comTerran Biosciences' Four Patent Applications Cover Improved Versions Of Classic EmpathogensMay 8, 2023 | marketwatch.comVedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease WeekMay 8, 2023 | marketwatch.comSilver-based Antimicrobial Agents Market Size 2023-2031 Industrial Regions by Absolute Reports | with [102 Pages]May 2, 2023 | marketwatch.comAntiseptics & Disinfectants Market Trends and Analysis: Exploring Future Growth Potential & its projected CAGR of 6.5% from 2023-2030April 19, 2023 | marketwatch.comDigestive Enzymes Market New Trend Analysis 2023-2030See More Headlines Receive PURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address PURE Company Calendar Last Earnings3/12/2020Today9/25/2023Next Earnings (Estimated)10/26/2023Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Miscellaneous chemical products Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PURE CUSIPN/A CIK1006028 Webwww.purebio.com Phone(619) 596-8600Fax619-596-8790Employees15Year Founded1992Profitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,490,000.00 Net Margins-247.89% Pretax Margin-247.89% Return on Equity-151.03% Return on Assets-123.25% Debt Debt-to-Equity RatioN/A Current Ratio2.16 Quick Ratio1.90 Sales & Book Value Annual Sales$1.81 million Price / Sales6.80 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book2.75Miscellaneous Outstanding Shares111,860,000Free Float64,407,000Market Cap$12.30 million OptionableNot Optionable Beta0.08 Social Links The Best High-Yield Dividend Stocks for 2023Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Robert F. Bartlett (Age 78)Pres, CEO & Director Mr. Mark Stuart Elliott (Age 48)VP of Fin. and Principal Financial & Accounting Officer Comp: $162kDr. Zhinong YanExec. VP of Technology & Bus. Devel.Mr. John KasperskiVP of SalesKey CompetitorsArtemis TherapeuticsOTCMKTS:ATMSAraviveNASDAQ:ARAVCingulateNASDAQ:CINGChemomab TherapeuticsNASDAQ:CMMBMedicureOTCMKTS:MCUJFView All Competitors PURE Stock - Frequently Asked Questions How have PURE shares performed in 2023? PURE Bioscience's stock was trading at $0.0848 on January 1st, 2023. Since then, PURE stock has increased by 29.8% and is now trading at $0.11. View the best growth stocks for 2023 here. Are investors shorting PURE Bioscience? PURE Bioscience saw a decline in short interest in the month of August. As of August 31st, there was short interest totaling 19,700 shares, a decline of 36.9% from the August 15th total of 31,200 shares. Based on an average daily volume of 54,100 shares, the days-to-cover ratio is currently 0.4 days. View PURE Bioscience's Short Interest. When is PURE Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, October 26th 2023. View our PURE earnings forecast. How were PURE Bioscience's earnings last quarter? PURE Bioscience, Inc. (OTCMKTS:PURE) announced its quarterly earnings results on Thursday, March, 12th. The company reported ($0.01) EPS for the quarter. The firm earned $0.35 million during the quarter. PURE Bioscience had a negative trailing twelve-month return on equity of 151.03% and a negative net margin of 247.89%. What other stocks do shareholders of PURE Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and What is PURE Bioscience's stock symbol? PURE Bioscience trades on the OTCMKTS under the ticker symbol "PURE." How do I buy shares of PURE Bioscience? Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is PURE Bioscience's stock price today? One share of PURE stock can currently be purchased for approximately $0.11. How much money does PURE Bioscience make? PURE Bioscience (OTCMKTS:PURE) has a market capitalization of $12.30 million and generates $1.81 million in revenue each year. The company earns $-3,490,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. How can I contact PURE Bioscience? PURE Bioscience's mailing address is 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA, 91730. The official website for the company is www.purebio.com. The company can be reached via phone at (619) 596-8600, via email at melliott@purebio.com, or via fax at 619-596-8790. This page (OTCMKTS:PURE) was last updated on 9/25/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.